NXPH4

NXPH4 is a glycoprotein that functions across diverse cancer contexts as a driver of metabolic reprogramming, cell cycle progression, and therapy resistance, while a Nxph4-expressing neuronal population separately governs social behavior [PMID:41639054, PMID:bio_10.1101_2025.03.10.642464]. Mechanistically, NXPH4 acts largely by stabilizing partner proteins: it maintains NDUFA4L2 protein to elevate reactive oxygen species and activate glycolysis in gemcitabine-resistant bladder cancer (PMID:35954445), it competitively binds the prolyl hydroxylase PHD4 to stabilize HIF1A and amplify HIF signaling in colorectal cancer (PMID:39164641), and it binds and destabilizes CDKN2A to drive cyclinD-CDK4/6-pRB-E2F cell cycle signaling in NSCLC (PMID:34919637). In prostate cancer, NXPH4 partially localizes to mitochondria and physically interacts with the one-carbon metabolism enzyme ALDH1L2; androgen deprivation stimulates its mitochondrial translocation and ALDH1L2 binding to promote metabolic reprogramming and enzalutamide resistance (PMID:41639054). Its expression is transcriptionally controlled by multiple upstream regulators across these contexts, including EZH2, ETS1, and the androgen receptor (PMID:34919637, PMID:41321684, PMID:41639054), and ETS1-driven NXPH4 suppresses apoptosis and GPX4 while promoting macrophage M2 polarization (PMID:41321684). Its own mRNA escapes RNautophagy-mediated degradation through an m5C-dependent mechanism (PMID:39164641). Beyond these cancer-context interactions and the hypothalamic neuronal role, no unifying biochemical activity for NXPH4 has been characterized in the available corpus.

1. 2022 Medium

   Established a first functional mechanism for NXPH4 in cancer by placing it upstream of NDUFA4L2 stability to control redox and glycolytic state in chemoresistance.

   Evidence Glycolytic and ROS assays with rescue experiments and in vivo validation in gemcitabine-resistant bladder cancer cells

   PMID:35954445

   Open questions at the time

   • No direct NXPH4–NDUFA4L2 binding/co-IP data described
   • Mechanism by which NXPH4 stabilizes NDUFA4L2 unknown
2. 2022 Medium

   Identified an EZH2→NXPH4→CDKN2A axis, showing NXPH4 destabilizes a tumor suppressor to engage cell cycle progression.

   Evidence siRNA knockdown, interaction assay, protein stability westerns, and cell cycle analysis in NSCLC cells

   PMID:34919637

   Open questions at the time

   • Binding assay methodology not rigorously detailed
   • Direct vs indirect destabilization of CDKN2A not resolved
   • Single lab, in vitro emphasis
3. 2024 Medium

   Defined how NXPH4 stabilizes HIF1A and how its own transcript is protected, linking NXPH4 to HIF signaling.

   Evidence Competitive PHD4 binding assays plus m5C-dependent RNautophagy studies in cells, organoids, and mouse models of colorectal cancer

   PMID:39164641

   Open questions at the time

   • Structural basis of PHD4 competition unknown
   • m5C writer/reader controlling NXPH4 mRNA not identified
   • Single lab
4. 2025 Medium

   Established ETS1 as a direct transcriptional activator of NXPH4 and tied NXPH4 to ferroptosis-related and immune phenotypes.

   Evidence ChIP, dual luciferase reporter, knockdown/overexpression rescue, flow cytometry, and in vivo tumor models in OSCC

   PMID:41321684

   Open questions at the time

   • Molecular link between NXPH4 and GPX4/M2 polarization unresolved
   • Single lab
5. 2026 High

   Demonstrated NXPH4 mitochondrial localization and ALDH1L2 binding under androgen deprivation, defining a context-dependent metabolic resistance mechanism.

   Evidence Subcellular fractionation, reciprocal co-IP, gain/loss-of-function studies, and mouse xenografts in prostate cancer cells

   PMID:41639054

   Open questions at the time

   • Consequence of ALDH1L2 binding on one-carbon flux not biochemically dissected
   • Trigger for mitochondrial translocation unclear
6. 2025 Medium

   Assigned a defined in vivo function to Nxph4-expressing neurons in regulating social motivation, distinct from the gene's cancer roles.

   Evidence Chemogenetic (DREADD) inhibition, single-nucleus RNA-seq, and behavioral assays in mice (preprint)

   PMID:bio_10.1101_2025.03.10.642464

   Open questions at the time

   • Preprint, single study
   • Molecular function of NXPH4 within these neurons not addressed
   • Cell-autonomous role of NXPH4 protein not tested

• A unifying biochemical activity for NXPH4 reconciling its multiple partner-stabilizing roles and its neuronal function remains undefined.
• No shared structural or enzymatic basis identified across NDUFA4L2, PHD4, CDKN2A, and ALDH1L2 interactions
• No structural model of NXPH4 complexes